tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CDTX Stock Latest News

Cidara Therapeutics Refocuses Strategy with Asset Sale
Company AnnouncementsCidara Therapeutics Refocuses Strategy with Asset Sale
11h ago
8K
CDTX
Cidara Therapeutics: Strategic Partnerships and Governance Changes
PremiumCompany Announcements
Cidara Therapeutics: Strategic Partnerships and Governance Changes
11h ago
8K
CDTX
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
PremiumPress Releases
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
12h ago
CDTX
Cidara Therapeutics’ Restatement Woes: Costs, Distractions, and Investor Confidence on the Line
PremiumCompany Announcements
Cidara Therapeutics’ Restatement Woes: Costs, Distractions, and Investor Confidence on the Line
1d ago
CDTX
Cidara Therapeutics trading halted, news pending
PremiumThe Fly
Cidara Therapeutics trading halted, news pending
1d ago
CDTX
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress ReleasesCidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
2d ago
CDTX
Cidara Therapeutics reports Q4 EPS (4c), consensus (10c)
PremiumThe Fly
Cidara Therapeutics reports Q4 EPS (4c), consensus (10c)
2d ago
CDTX
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
PremiumPress Releases
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
2d ago
CDTX
Cidara Therapeutics discloses Nasdaq listing deficiency notice
PremiumThe Fly
Cidara Therapeutics discloses Nasdaq listing deficiency notice
2d ago
CDTX
Cidara Therapeutics announces 1-for-20 reverse stock split
PremiumThe Fly
Cidara Therapeutics announces 1-for-20 reverse stock split
3d ago
CDTX
Cidara Therapeutics Announces Reverse Stock Split
PremiumPress Releases
Cidara Therapeutics Announces Reverse Stock Split
3d ago
CDTX
Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress Releases
Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024
20d ago
CDTX
CDTX Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCDTX Upcoming Earnings Report: What to Expect?
2M ago
CDTX
Cidara Therapeutics receives $11.14M milestone payment from Mundipharma
PremiumThe Fly
Cidara Therapeutics receives $11.14M milestone payment from Mundipharma
2M ago
CDTX
Cidara Therapeutics Granted Nasdaq Listing Extension
PremiumCompany Announcements
Cidara Therapeutics Granted Nasdaq Listing Extension
2M ago
8K
CDTX
Cidara spikes 20% after MHRA approval of Rezzayo for invasive candidiasis
PremiumThe Fly
Cidara spikes 20% after MHRA approval of Rezzayo for invasive candidiasis
3M ago
CDTX
Cidara gets $2.8M milestone payment from Mundipharma for MHRA’s Rezzayo approval
PremiumThe Fly
Cidara gets $2.8M milestone payment from Mundipharma for MHRA’s Rezzayo approval
3M ago
CDTX
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
PremiumPress Releases
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
3M ago
CDTX
MHRA approves Cidara Therapeutics’ Rezzayo for invasive candidiasis in adults
PremiumThe Fly
MHRA approves Cidara Therapeutics’ Rezzayo for invasive candidiasis in adults
3M ago
CDTX
Cidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults
PremiumPress ReleasesCidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adults
4M ago
CDTX
Cidara announces REZZAYO approved in EU for treatment of candidiasis in Adults
PremiumThe Fly
Cidara announces REZZAYO approved in EU for treatment of candidiasis in Adults
4M ago
CDTX
Cidara presents new preclinical data on drug-Fc conjugate candidate
PremiumThe Fly
Cidara presents new preclinical data on drug-Fc conjugate candidate
5M ago
CDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >